Filtered By:
Infectious Disease: Hepatitis
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 32429 results found since Jan 2013.
Unusual Initial Presentation of Hepatocellular Carcinoma as a Clavicular Head Mass
CONCLUSIONS: This case demonstrates a very unusual HCC presentation, the importance of a thorough workup of bone metastasis, and the limited value of AFP for HCC screening, even in disseminated disease.PMID:37616520 | DOI:10.46883/2023.25921003
Source: Oncology (Williston Park, N.Y.) - August 24, 2023 Category: Cancer & Oncology Authors: Rohit Gupta Joshua Hirsch Maya Guhan Jeffrey Triska Ruben Hernaez Addison Taylor Source Type: research
Rat Hepatitis E Virus in Norway Rats, Ontario, Canada, 2018-2021
Emerg Infect Dis. 2023 Sep;29(9):1890-1894. doi: 10.3201/eid2909.230517.ABSTRACTWe tested liver samples from 372 Norway rats (Rattus norvegicus) from southern Ontario, Canada, during 2018-2021 to investigate presence of hepatitis E virus infection. Overall, 21 (5.6%) rats tested positive for the virus. Sequence analysis demonstrated all infections to be rat hepatitis E virus (Rocahepevirus ratti genotype C1).PMID:37610234 | DOI:10.3201/eid2909.230517
Source: Emerging Infectious Diseases - August 23, 2023 Category: Infectious Diseases Authors: Sarah J Robinson Jamie Borlang Chelsea G Himsworth David L Pearl J Scott Weese Antonia Dibernardo Carla Osiowy Neda Nasheri Claire M Jardine Source Type: research
Drug-related adverse reactions in pediatric Inflammatory Bowel Disease
This article is protected by copyright. All rights reserved.PMID:37611322 | DOI:10.1002/jcph.2339
Source: The Journal of Clinical Pharmacology - August 23, 2023 Category: Drugs & Pharmacology Authors: Ana Losa Rita Gomes Francisco Ribeiro Mour ão Sandra Soares Cardoso Paula Manuel Vieira M ário Rui Correia Helena Moreira Silva Gisela Silva Marta Tavares Ermelinda Santos Silva Rosa Lima Source Type: research
Oncogenic β-catenin-driven liver cancer is susceptible to methotrexate-mediated disruption of nucleotide synthesis
CONCLUSION: MTX is a promising chemotherapeutic agent for β-catenin hyperactive liver cancer. Since repurposing MTX has the advantages of lower risk, shorter timelines, and less investment in drug discovery and development, a clinical trial is warranted to test its efficacy in the treatment of β-catenin mutant liver cancer.PMID:37612257 | DOI:10.1097/CM9.0000000000002816
Source: Chinese Medical Journal - August 23, 2023 Category: General Medicine Authors: Fangming Liu Yuting Wu Baohui Zhang Shuhui Yang Kezhuo Shang Jie Li Pengju Zhang Weiwei Deng Linlin Chen Liang Zheng Xiaochen Gai Hongbing Zhang Source Type: research
